<VariationArchive VariationID="3244192" VariationName="NC_000013.10:g.(?_48517506)_(48575405_?)del" VariationType="Deletion" Accession="VCV003244192" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3405075" VariationID="3244192">
      <GeneList>
        <Gene Symbol="SUCLA2" FullName="succinate-CoA ligase ADP-forming subunit beta" GeneID="8803" HGNC_ID="HGNC:11448" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="47942656" stop="48001273" display_start="47942656" display_stop="48001273" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48516790" stop="48575461" display_start="48516790" display_stop="48575461" Strand="-" />
          </Location>
          <OMIM>603921</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000013.10:g.(?_48517506)_(48575405_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" innerStart="48517506" innerStop="48575405" display_start="48517506" display_stop="48575405" variantLength="57900" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.(?_48517506)_(48575405_?)del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.(?_48517506)_(48575405_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000013.10:g.(?_48517506)_(48575405_?)del AND Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" Accession="RCV004578314" Version="1">
        <ClassifiedConditionList TraitSetID="6286">
          <ClassifiedCondition DB="MedGen" ID="C2749864">Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15877282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17301081</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26475597</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5549" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalomyopathy</ElementValue>
                <XRef ID="Encephalomyopathy/2524" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial encephalomyopathy aminoacidopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria</ElementValue>
                <XRef ID="MONDO:0012791" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED</ElementValue>
                <XRef Type="MIM" ID="612073" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MTDPS5</ElementValue>
                <XRef Type="MIM" ID="612073" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form, with Mild Methylmalonic Aciduria</Attribute>
                <XRef ID="NBK6803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following features in infancy or childhood (median age of onset 2 months; range of onset birth to 6 years): psychomotor retardation, hypotonia, dystonia, muscular atrophy, sensorineural hearing impairment, postnatal growth retardation, and feeding difficulties. Other less frequent features include distinctive facial features, contractures, kyphoscoliosis, gastroesophageal reflux, ptosis, choreoathetosis, ophthalmoplegia, and epilepsy (infantile spasms or generalized convulsions). The median survival is 20 years; approximately 30% of affected individuals succumb during childhood. Affected individuals may have hyperintensities in the basal ganglia, cerebral atrophy, and leukoencephalopathy on head MRI. Elevation of methylmalonic acid (MMA) in the urine and plasma is found in a vast majority of affected individuals, although at levels that are far below those typically seen in individuals with classic methylmalonic aciduria.</Attribute>
                <XRef ID="NBK6803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3681" />
                <XRef ID="3681" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301762</ID>
                <ID Source="BookShelf">NBK6803</ID>
              </Citation>
              <XRef ID="1933" DB="Orphanet" />
              <XRef ID="C2749864" DB="MedGen" />
              <XRef ID="MONDO:0012791" DB="MONDO" />
              <XRef Type="MIM" ID="612073" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9834696" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000013.10:g.(?_48517506)_(48575405_?)del|MedGen:C2749864" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005067024" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15877282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17301081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26475597</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the SUCLA2 gene has been identified. Loss-of-function variants in SUCLA2 are known to be pathogenic (PMID: 15877282, 17301081). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. For these reasons, this variant has been classified as Pathogenic. Isolated whole-gene deletions of SUCLA2 have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 26475597).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.(?_48517506)_(48575405_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2749864" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9834696" TraitType="Disease" MappingType="XRef" MappingValue="C2749864" MappingRef="MedGen">
        <MedGen CUI="C2749864" Name="Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

